Literature DB >> 8879922

Delayed-type hypersensitivity to subcutaneous lidocaine with tolerance to articaine: confirmation by in vivo and in vitro tests.

A J Bircher1, S L Messmer, C Surber, T Rufli.   

Abstract

A 43-year-old woman suffered from recurrent localized swellings and an eczematous dermatitis starting 1 day after an injection of lidocaine. Intradermal patch and lymphocyte transformation tests revealed sensitization to lidocaine and cross-reactivity to the other aminoacylamide local anesthetics bupivacaine, mepivacaine and prilocaine, but not to articane. Contact allergy to the ester local anesthetics benzocaine, procaine and tetracaine, the quinoline or aminoacylamide cinchocaine, and the preservatives methylparaben and metabisulfite, was excluded. A subcutaneous challenge with articaine was well tolerated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879922     DOI: 10.1111/j.1600-0536.1996.tb02238.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  3 in total

Review 1.  Adverse effects and drug interactions associated with local and regional anaesthesia.

Authors:  M Naguib; M M Magboul; A H Samarkandi; M Attia
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

2.  A case of postoperative bullous allergic contact dermatitis caused by injection with lidocaine.

Authors:  Angelique N Voorberg; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2019-05-21       Impact factor: 6.600

3.  Allergy to lidocaine injections: comparison of patient history with skin testing in five patients.

Authors:  Dorota Jenerowicz; Adriana Polańska; Olga Glińska; Magdalena Czarnecka-Operacz; Robert A Schwartz
Journal:  Postepy Dermatol Alergol       Date:  2014-06-13       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.